Obstructive sleep apnea syndrome: literature review

Cover Page

Cite item

Full Text

Abstract

The objective of this article was to analyze and summarize the available data on obstructive sleep apnea syndrome as a risk factor for the occurrence and aggravation of the cardiovascular system diseases. This review presents the materials of domestic and foreign authors about risk factors and their prevention. 52 different literature sources were used — articles published in the international citation databases PubMed (MEDLINE), Scopus, as well as fundamental research published in the Russian Science Citation Index (RSCI), monographs. The data were selected by keywords: "cardiovascular diseases", "risk factors", "arterial hypertension", "chronic cardiac insufficiency", "atrial fibrillation", "apnea". Materials whose authorship has not been established, textbooks, near-scientific Internet resources, as well as those that do not correspond to the subject of the study were excluded from the analysis. Sleep apnea is a widespread, but not often detected disease among patients with cardiovascular pathologies. Further study of methods of diagnosis and treatment of sleep apnea is a promising direction in terms of working on risk factors and the effectiveness of cardiovascular diseases treatment.

About the authors

Nina A. Surikova

Orenburg State Medical University

Author for correspondence.
Email: nina70494@mail.ru
ORCID iD: 0000-0001-8833-7043
SPIN-code: 7891-0830

graduate student

Russian Federation, Orenburg

Anna S. Glukhova

Pokrovskaya City Hospital

Email: ichi_08@mail.ru
ORCID iD: 0000-0001-8220-6739
SPIN-code: 6082-6140

cardiologist

Russian Federation, St. Petersburg

References

  1. Palman AD, Akselrod AS. Ventricular arrhythmias in a patient with obstructive sleep apnea syndrome and its effective non-pharmaceutical treatment. Almanac of Clinical Medicine. 2021;49(2):165–170. (In Russ). doi: 10.18786/2072-0505-2021-49-031
  2. Kantimirova EA. Modern methods of differential diagnosis of central and obstructive sleep apnea. Vestnik Klinicheskoi bol'nitsy № 51. 2012;1–2:34–37. (In Russ).
  3. Rubina SS, Makarova II. Obstructive sleep apnea: a modern view of the problem. Ural Medical Journal. 2021;20(4):85–92. (In Russ). doi: 10.52420/2071-5943-2021-20-4-85-92
  4. Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail. 2016;4(2):116–125. doi: 10.1016/j.jchf.2015.09.014
  5. Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ). doi: 10.15829/1560-4071-2020-3-3786
  6. Evlampieva LG, Yaroslavskaya EI, Kharats VE. Relationships between obstructive sleep apnea syndrome and cardiovascular risk factors. The Siberian Journal of Clinical and Experimental Medicine. 2021;36(1):58–65. (In Russ). doi: 10.29001/2073-8552-2021-36-1-58-65
  7. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e56–e67. doi: 10.1161/CIR.0000000000000988. Erratum in: Circulation. 2022;145(12):e775.
  8. Warchol-Celinska E, Prejbisz A, Kadziela J, et al. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial. Hypertension. 2018;72(2):381–390. doi: 10.1161/HYPERTENSIONAHA.118.11180
  9. Johnson DA, Thomas SJ, Abdalla M, et al. Association Between Sleep Apnea and Blood Pressure Control Among Blacks. Circulation. 2019;139(10):1275–1284. doi: 10.1161/CIRCULATIONAHA.118.036675
  10. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90(1):47–112. doi: 10.1152/physrev.00043.2008
  11. Kwon Y, Debaty G, Puertas L, et al. Effect of regulating airway pressure on intrathoracic pressure and vital organ perfusion pressure during cardiopulmonary resuscitation: a non-randomized interventional cross-over study. Scand J Trauma Resusc Emerg Med. 2015;23:83. doi: 10.1186/s13049-015-0164-5
  12. Tolle FA, Judy WV, Yu PL, Markand ON. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(6):1718–1724. doi: 10.1152/jappl.1983.55.6.1718
  13. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897–904. doi: 10.1172/JCI118235
  14. Sforza E, Roche F. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach. Hypoxia (Auckl). 2016;4:99–108. doi: 10.2147/HP.S10309
  15. Arredondo E, Udeani G, Panahi L, et al. Obstructive Sleep Apnea in Adults: What Primary Care Physicians Need to Know. Cureus. 2021;13(9):e17843. doi: 10.7759/cureus.17843
  16. Silveira MG, Sampol G, Mota-Foix M, et al. Cluster-derived obstructive sleep apnea phenotypes and outcomes at 5-year follow-up. J Clin Sleep Med. 2022;18(2):597–607. doi: 10.5664/jcsm.9674
  17. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407–2415. doi: 10.1001/jama.2013.281250
  18. Javaheri S, Gottlieb DJ, Quan SF. Effects of continuous positive airway pressure on blood pressure in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). J Sleep Res. 2019;29(2):e12943. doi: 10.1111/jsr.12943
  19. Walia HK, Li H, Rueschman M, et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med. 2014;10(8):835–843. doi: 10.5664/jcsm.3946
  20. Deleanu OC, Oprea CI, Malaut AE, et al. Long-term effects of CPAP on blood pressure in non-resistant hypertensive patients with obstructive sleep apnea: A 30 month prospective study. European Respiratory Journal. 2016;48:PA2082. doi: 10.1183/13993003.congress-2016.PA2082
  21. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384. doi: 10.1056/NEJM200005113421901
  22. O’Connor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179(12):1159–1164. doi: 10.1164/rccm.200712-1809OC
  23. Aksenova AV, Sivakova OA, Blinova NV, et al. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv. 2021;93(9):1018–1029. (In Russ). doi: 10.26442/00403660.2021.09.201007
  24. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169–2176. doi: 10.1001/jama.2012.3418
  25. Mokhlesi B, Varga AW. Obstructive Sleep Apnea and Cardiovascular Disease. REM Sleep Matters! Am J Respir Crit Care Med. 2018;197(5):554–556. doi: 10.1164/rccm.201710-2147ED
  26. Baimukanov AM, Bulavina IA, Petrova GA, et al. Sleep apnea in patients with atrial fibrillation. Lechebnoe Delo. 2022;2:132–136. (In Russ). doi: 10.24412/2071-5315-2022-12817
  27. Tung P, Levitzky YS, Wang R, et al. Obstructive and Central Sleep Apnea and the Risk of Incident Atrial Fibrillation in a Community Cohort of Men and Women. J Am Heart Assoc. 2017;6(7):e004500. doi: 10.1161/JAHA.116.004500
  28. Kharats VE. The problem of association between obstructive sleep apnea and atrial fibrillation in cardiology practice. The Siberian Journal of Clinical and Experimental Medicine. 2022;37(3):41–48. (In Russ). doi: 10.29001/2073-8552-2022-37-3-41-48
  29. Ostroumova OD, Isaev RI, Kotovskaya YV, Tkacheva ON. Drugs affecting obstructive sleep apnea syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(9–2):46–54. (In Russ). doi: 10.17116/jnevro202012009146
  30. Linz D, McEvoy RD, Cowie MR, et al. Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review. JAMA Cardiol. 2018;3(6):532–540. doi: 10.1001/jamacardio.2018.0095
  31. Oldenburg O, Lamp B, Faber L, et al. Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Failure. 2007;9(3):251–257. doi: 10.1016/j.ejheart.2006.08.003
  32. Sanchez AM, Germany R, Lozier MR, et al. Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications. Int J Cardiol Heart Vasc. 2020;30:100527. doi: 10.1016/j.ijcha.2020.100527
  33. Chen L, Zadi ZH, Zhang J, et al. Intermittent hypoxia in utero damages postnatal growth and cardiovascular function in rats. J Appl Physiol (1985). 2018;124(4):821–830. doi: 10.1152/japplphysiol.01066.2016
  34. Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102(11):1557–1561. doi: 10.1016/j.amjcard.2008.07.050
  35. Khayat RN, Abraham WT, Patt B, et al. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea. Chest. 2008;134(6):1162–1168. doi: 10.1378/chest.08-0346
  36. Javaheri S, Javaheri S. Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions. J Clin Med. 2022;11(12):3458. doi: 10.3390/jcm11123458
  37. Gunta SP, Jakulla RS, Ubaid A, et al. Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022. Cardiovasc Ther. 2022;2022:6006127. doi: 10.1155/2022/6006127
  38. O΄Donnell C, O΄Mahony AM, McNicholas WT, Ryan S. Cardiovascular manifestations in obstructive sleep apnea: current evidence and potential mechanisms. Polish Arch Internal Med. 2021;131(6):550–560. doi: 10.20452/pamw.16041
  39. Newman SB, Kundel V, Matsuzaki M, et al. Sleep apnea, coronary artery calcium density, and cardiovascular events: results from the Multi-Ethnic Study of Atherosclerosis. J Clin Sleep Med. 2021;17(10):2075–2083. doi: 10.5664/jcsm.9356
  40. Mooe T, Franklin KA, Wiklund U, et al. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest. 2000;117(6):1597–1602. doi: 10.1378/chest.117.6.1597
  41. Wang X, Zhang Y, Dong Z, et al. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis. Respir Res. 2018;19(1):61. doi: 10.1186/s12931-018-0761-8
  42. Aksenova AV, Sivakova OA, Blinova NV, et al. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv. 2021;93(9):1018–1029. (In Russ). doi: 10.26442/004036
  43. Buzunov RV, Palman AD, Melnikov AYu, et al. Diagnostics and Treatment of Obstructive Sleep Apnea Syndrome in Adults. Recommendations of the Russian Society of Sleep Medicine. Effektivnaya farmakoterapiya. Nevrologiya. Spetsvypusk «Son i ego rasstroistva». 2018;35:34–45. (In Russ).
  44. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–821. doi: 10.1097/ALN.0b013e31816d83e4
  45. Fudim M, Shahid I, Emani S, et al. Evaluation and treatment of central sleep apnea in patients with heart failure. Curr Probl Cardiol. 2022;47(12):101364. doi: 10.1016/j.cpcardiol.2022.101364
  46. Tran NT, Tran HN, Mai AT. A wearable device for at-home obstructive sleep apnea assessment: State-of-the-art and research challenges. Front Neurol. 2023;14:1123227. doi: 10.3389/fneur.2023.1123227
  47. Monda VM, Gentile S, Porcellati F, et al. Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes. Adv Ther. 2022;39(11):4837–4846. doi: 10.1007/s12325-022-02310-2
  48. Buzunov RV. Obesity and Obstructive Sleep Apnea: How to Break the Vicious Circle. Effektivnaya farmakoterapiya. 2020;16(2):30–33. (In Russ).
  49. Brulé D, Villano C, Davies LJ, et al. The grapevine (Vitis vinifera) LysM receptor kinases VvLYK1-1 and VvLYK1-2 mediate chitooligosaccharide-triggered immunity. Plant Biotechnol J. 2019;17(4):812–825. doi: 10.1111/pbi.13017
  50. Chang HP, Chen YF, Du JK. Obstructive sleep apnea treatment in adults. Kaohsiung J Med Sci. 2020;36(1):7–12. doi: 10.1002/kjm2.12130
  51. Gorbunova MV, Babak SL, Malyavin AG. Modern algorithm for the diagnosis and treatment of cardiovascular and metabolic disorders in patients with obstructive sleep apnea. Lechebnoe Delo. 2019. № 1. (In Russ). doi: 10.24411/2071-5315-2019-12086
  52. Akashiba T, Inoue Y, Uchimura N, et al. Sleep apnea syndrome (SAS) clinical practice guidelines 2020. Respir Investig. 2022;60(1):3–32. doi: 10.1016/j.resinv.2021.08.010

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies